Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders

Hippocampus serves as a pivotal role in cognitive and emotional processes, as well as in the regulation of the hypothalamus-pituitary axis. It is known to undergo mild neurodegenerative changes during normal aging and severe atrophy in Alzheimer’s disease. Furthermore, dysregulation in the hippocamp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chiavellini, Priscila, Canatelli Mallat, Martina, Lehmann, Marianne, Goya, Rodolfo Gustavo, Morel, Gustavo Ramón
Formato: Articulo
Lenguaje:Inglés
Publicado: 2021
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/151826
Aporte de:
id I19-R120-10915-151826
record_format dspace
spelling I19-R120-10915-1518262023-04-20T04:08:31Z http://sedici.unlp.edu.ar/handle/10915/151826 issn:1876-7958 Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders Chiavellini, Priscila Canatelli Mallat, Martina Lehmann, Marianne Goya, Rodolfo Gustavo Morel, Gustavo Ramón 2021-08-04 2023-04-19T18:54:24Z en Ciencias Médicas aging Alzheimer’s disease cell reprogramming epilepsy gene therapy glial cell line-derived neurotrophic factor hippocampus major depression Hippocampus serves as a pivotal role in cognitive and emotional processes, as well as in the regulation of the hypothalamus-pituitary axis. It is known to undergo mild neurodegenerative changes during normal aging and severe atrophy in Alzheimer’s disease. Furthermore, dysregulation in the hippocampal function leads to epilepsy and mood disorders. In the first section, we summarized the most salient knowledge on the role of glial cell-line-derived neurotrophic factor and its receptors focused on aging, cognition and neurodegenerative and hippocampal-related neurological diseases mentioned above. In the second section, we reviewed the therapeutic approaches, particularly gene therapy, using glial cell-line-derived neurotrophic factor or its gene, as a key molecule in the development of neurological disorders. In the third section, we pointed at the potential of regenerative medicine, as an emerging and less explored strategy for the treatment of hippocampal disorders. We briefly reviewed the use of partial reprogramming to restore brain functions, non-neuronal cell reprogramming to generate neural stem cells, and neural progenitor cells as source-specific neuronal types to be implanted in animal models of specific neurodegenerative disorders. Instituto de Investigaciones Bioquímicas de La Plata Articulo Articulo http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) application/pdf 469-476
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Ciencias Médicas
aging
Alzheimer’s disease
cell reprogramming
epilepsy
gene therapy
glial cell line-derived neurotrophic factor
hippocampus
major depression
spellingShingle Ciencias Médicas
aging
Alzheimer’s disease
cell reprogramming
epilepsy
gene therapy
glial cell line-derived neurotrophic factor
hippocampus
major depression
Chiavellini, Priscila
Canatelli Mallat, Martina
Lehmann, Marianne
Goya, Rodolfo Gustavo
Morel, Gustavo Ramón
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
topic_facet Ciencias Médicas
aging
Alzheimer’s disease
cell reprogramming
epilepsy
gene therapy
glial cell line-derived neurotrophic factor
hippocampus
major depression
description Hippocampus serves as a pivotal role in cognitive and emotional processes, as well as in the regulation of the hypothalamus-pituitary axis. It is known to undergo mild neurodegenerative changes during normal aging and severe atrophy in Alzheimer’s disease. Furthermore, dysregulation in the hippocampal function leads to epilepsy and mood disorders. In the first section, we summarized the most salient knowledge on the role of glial cell-line-derived neurotrophic factor and its receptors focused on aging, cognition and neurodegenerative and hippocampal-related neurological diseases mentioned above. In the second section, we reviewed the therapeutic approaches, particularly gene therapy, using glial cell-line-derived neurotrophic factor or its gene, as a key molecule in the development of neurological disorders. In the third section, we pointed at the potential of regenerative medicine, as an emerging and less explored strategy for the treatment of hippocampal disorders. We briefly reviewed the use of partial reprogramming to restore brain functions, non-neuronal cell reprogramming to generate neural stem cells, and neural progenitor cells as source-specific neuronal types to be implanted in animal models of specific neurodegenerative disorders.
format Articulo
Articulo
author Chiavellini, Priscila
Canatelli Mallat, Martina
Lehmann, Marianne
Goya, Rodolfo Gustavo
Morel, Gustavo Ramón
author_facet Chiavellini, Priscila
Canatelli Mallat, Martina
Lehmann, Marianne
Goya, Rodolfo Gustavo
Morel, Gustavo Ramón
author_sort Chiavellini, Priscila
title Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
title_short Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
title_full Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
title_fullStr Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
title_full_unstemmed Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
title_sort therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
publishDate 2021
url http://sedici.unlp.edu.ar/handle/10915/151826
work_keys_str_mv AT chiavellinipriscila therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders
AT canatellimallatmartina therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders
AT lehmannmarianne therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders
AT goyarodolfogustavo therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders
AT morelgustavoramon therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders
_version_ 1765660031161729024